Work Here?
Alector develops therapies aimed at treating neurodegenerative diseases like Alzheimer's and Parkinson's. The company focuses on research and development of new drug candidates by utilizing knowledge from immunology, neurology, and human genetics. Their approach involves conducting early-stage clinical trials to gather specific data about diseases, which helps improve the chances of success for their treatments. Alector differentiates itself from competitors by emphasizing the body's natural healing processes in their drug development. The company's goal is to create effective treatments for conditions that currently have limited options, while also securing funding through partnerships and grants to support their research efforts.
Company Stage
IPO
Employees
201-500
Industries
Consulting, Hardware, Biotechnology, Healthcare
Total Funding
$269.5M
Headquarters
N/A
Founded
2013
Find jobs on Simplify and start your career today